Results 61 to 70 of about 4,131 (101)

[Progress in the treatment of sarcopenia in patients with cirrhosis]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2023
Zhang JT   +5 more
europepmc   +1 more source

肝炎后肝硬化患者尿血栓素B2和6-酮-前列腺素F1α与肾功能的关系

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1990
用放射免疫法测定了45例肝炎后肝硬化患者尿血栓素B2和6-酮-前列腺素F1α的排泄率。结果,肝硬化患者尿血栓素B2排泄率较正常对照明显升高;肝硬化无并肾衰者尿6-酮-PGF1α较对照组升高;但并有肾衰者尿6-酮-前列腺素F1α排泄率比无并肾衰者则显著降低 ...
doaj  

[Exploring the advantages of traditional Chinese medicine and dual-anti therapy for liver cirrhosis]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Li YQ   +5 more
europepmc   +1 more source

[Analysis of portal vein thrombosis formation and risk factors after endoscopic treatment in patients with esophagogastric varices in liver cirrhosis]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Cui YQ   +9 more
europepmc   +1 more source

[Guidelines on the management of ascites in cirrhosis (2023 version)]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2023
Chinese Society of Hepatology   +1 more
europepmc   +1 more source

[Research progress on the correlation between cirrhosis and frailty]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2023
Zhao YF, Zheng MY, Zhu HL, Yang JH.
europepmc   +1 more source

Home - About - Disclaimer - Privacy